Skip to main content

Stanford to Use Rosetta Biosoftware

NEW YORK (GenomeWeb News) – Stanford University has licensed Rosetta Biosoftware's genetic data analysis software for use in its insulin sensitivity research program, the company said today.

The university licensed the Syllego system for managing and analyzing genetic data produced by the GENEticS of Insulin Sensitivity (GENESIS) consortium. The software will support genome-wide association studies of the genetic mechanisms underlying insulin sensitivity.

The diabetes genome studies so far have revealed genes associated with insulin production and have not focused on sensitivity to insulin in peripheral tissues.

The GENESIS consortium studies include cohorts of thousands of patients in whom insulin action is measured as a primary phenotype, the company said.

The Syllego system is designed to provide support for managing and analyzing genome-wide, copy number variation, linkage, and eQTL data. It works as a collaborative platform that enables research team members to access and interpret data within a single interface.

Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.